The Journal of Molecular Pathology is proud to announce its acceptance for indexing in Scopus as of May 20, 2024. This achievement is a testament to the high quality of research and scholarship contributed by authors, reviewers, and editors associated with the journal.
The Journal of Molecular Pathology is at the forefront of advancing precision and personalized medicine by transforming conventional histopathology and cytopathology. In an era where molecular pathology is becoming increasingly pivotal, JMP serves as a crucial platform for pathologists and researchers to engage with cutting-edge developments in the field. The journal focuses on the integration and dissemination of original research and educational content pertinent to molecular pathology and its allied disciplines.
JMP publishes a variety of content types, including reviews, regular research papers, and short communications. Special Issues on specific topics are also featured, encouraging detailed and comprehensive reporting of experimental and theoretical results. The journal's open-access model ensures that all published content is freely available to the global scientific community, promoting wider dissemination and impact of the research.
To continue fostering high-quality research, the Journal of Molecular Pathology invites scientists and researchers to submit their manuscripts. The journal does not impose restrictions on the length of submitted papers, allowing for full experimental details to be included, which facilitates reproducibility and further scientific inquiry.
Researchers interested in contributing to JMP can submit their papers via the following link: https://www.mdpi.com/journal/jmp.
Click here to read the original press release.
